3 results
The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 -
Moderate Risk (ASCVD ... > 20%) <-> MACE ... Increased bleeding ASCEND ... mortality #Aspirin #VisualAbstract ... #ARRIVE #ASCEND
AACE/ACE ASCVD Risk Factor Modifications Algorithm

#ASCVD #RiskFactor #Modifications #Algorithm #Management #AACE
AACE/ACE ASCVD Risk ... Modifications Algorithm ... #ASCVD #RiskFactor ... Modifications #Algorithm ... #Management #AACE
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
events in T2DM + ASCVD ... events in T2DM + ASCVD ... or ASCVD risk; ... , in T2DM + ASCVD ... or ASCVD risk.